Form D — Aprea Therapeutics, Inc.
0001781983-25-000003 · filed 2025-12-29
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $5,783,766
- Total sold
- $3,055,822
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aprea Therapeutics, Inc.
- CIK
- 1781983
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3805 OLD EASTON ROAD
DOYLESTOWN, PA 18902 - Phone
- 215-948-4119
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Oren Gilad · Executive OfficerDoylestown, PA Find on LinkedIn ↗
-
John P. Hamill · Executive OfficerDoylestown, PA Find on LinkedIn ↗
-
Richard Peters · DirectorDoylestown, PA Find on LinkedIn ↗
-
Jean-Pierre Bizzari · DirectorDoylestown, PA Find on LinkedIn ↗
-
Marc Duey · DirectorDoylestown, PA Find on LinkedIn ↗
-
Michael Grissinger · DirectorDoylestown, PA Find on LinkedIn ↗
-
Gabriela Gruia · DirectorDoylestown, PA Find on LinkedIn ↗
-
John B. Henneman · DirectorDoylestown, PA Find on LinkedIn ↗
-
Rifat Pamukcu · DirectorDoylestown, PA Find on LinkedIn ↗
-
Bernd Seizinger · DirectorDoylestown, PA Find on LinkedIn ↗
View original on SEC EDGAR.